UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Delaware 20-5894890 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 par value CRMD Nasdaq Global Market Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging Growth Company ☐ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION ...

CorMedix Inc. (NASDAQ:CRMD) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET Company Participants Daniel Ferry - LifeSci Advisors, Investor Relations Matt David - Interim Chief Executive Officer, Executive Vice President and Chief Financial Officer Phoebe Mounts - Executive Vice President and General Counsel Conference Call Participants Jason Butler - JMP Securities LLC Joon Lee - Truist Securities, Inc. Rohit Bhasin - Needham & Company Operator Good afternoon, and welcome to the CorMedix's Fourth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Delaware 20-5894890 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922 (Address of Principal Executive Offices) (Zip Code) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 Par Value CRMD Nasdaq Global Market FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX ...

CorMedix Inc. (NASDAQ:CRMD) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Dan Ferry - LifeSci Advisors, IR Matt David - Interim CEO, EVP, and CFO Phoebe Mounts - EVP and General Counsel Conference Call Participants Jason Butler - JMP Securities Rohit Bhasin - Needham & Company Operator Good afternoon and welcome to the CorMedix's Third Quarter Earnings Conference Call. Today's conference call is being recorded. There will be a question-and-answer session At this time, all ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Delaware 20-5894890 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 par value CRMD The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION RE ...

CorMedix Inc. (NASDAQ:CRMD) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Dan Ferry - LifeSci Advisors, IR Khoso Baluch - CEO Phoebe Mounts - EVP and General Counsel Matt David - EVP and CFO Conference Call Participants Jason Butler - JMP Securities Joon Lee - Truist Securities Chad Messer - Needham & Company Operator Greetings and welcome to the CorMedix Inc. Second Quarter 2021 Earnings Conference Call. At this time, all participants are on a listen-only mode. A question ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-34673 CORMEDIX INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorpo ...

CorMedix Inc. (NASDAQ:CRMD) Q1 2021 Results Conference Call May 13, 2021 4:30 PM ET Company Participants Daniel Ferry - Investor Relations Khoso Baluch - Chief Executive Officer Thomas Nusbickel - Executive Vice President and Chief Commercial Officer Phoebe Mounts - Executive Vice President and General Counsel Elizabeth Masson-Hurlburt - Executive Vice President for Clinical Operations Matthew David - Executive Vice President and Chief Financial Officer Conference Call Participants Jason Butler - JMP Securi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Delaware 20-5894890 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file numb ...

& CorMedix™ Corporate Presentation April 2021 DefenCath™: A potentially new standard-of-care in the prevention of catheter related blood stream infections Forward-Looking Statements This presentation contains certain statements that constitute forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are not guarantees of future performance a ...